Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study.  Sutter MB, Watson H, Yonke N, Weitzen S, Leeman L.  BMC Pediatr. 2022 Jun 15;22(1):345. doi: 10.1186/s12887-022-03401-3. PMID: 35705…

A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome.  van…

Implementation of a Standardized Clinical Definition of Opioid Withdrawal in the Neonate: Challenges and Opportunities.  Jilani SM, Jones HE, Davis JM.  JAMA. 2022;327(17):1643–1644. doi:10.1001/jama.2022.5406 https://jamanetwork.com/jo…

Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.  Mahnke AH, Roberts MH, Leeman L, Ma X, Bakhireva LN, Miranda RC.  Sci Rep. 2022 Apr 8;12(1):5941. d…

Improving Outcomes through a Neonatal Abstinence Syndrome Collaborative in Maryland.  DiPietro B, Silcox K, Rost J, Woods L, Edwards EM, Buus-Frank M, Horbar J, Hudak M.  Am J Perinatol. 2022 Apr 5. doi: 10.1055/a-1817-5522. Epub ahead o…

Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta-analysis.  Haan, E, Westmoreland, KE, Schellhas, L, Sallis, HM, Taylor, G, Zuccolo, L, et al.  A…